{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:24:22Z","timestamp":1787984662113,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1245\/s10434-023-14145-4","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T16:03:39Z","timestamp":1693065819000},"page":"7848-7857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"30","author":[{"given":"Andrei","family":"Nikiforchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Iugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Pawlikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"issue":"9","key":"14145_CR1","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/codi.15778","volume":"23","author":"JC Kong","year":"2021","unstructured":"Kong JC, Flood MP, Guerra GR, et al. Appendiceal pseudomyxoma peritonei: predictors of recurrence and iterative surgery. Colorectal Dis. 2021;23(9):2368\u201375.","journal-title":"Colorectal Dis"},{"issue":"11","key":"14145_CR2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00432-013-1517-y","volume":"139","author":"L Ung","year":"2013","unstructured":"Ung L, Chua TC, David LM. Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy. J Cancer Res Clin Oncol. 2013;139(11):1899\u2013908.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"14145_CR3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/0959-8049(96)00178-5","volume":"32a","author":"FA Zoetmulder","year":"1996","unstructured":"Zoetmulder FA, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer. 1996;32a(10):1727\u201333.","journal-title":"Eur J Cancer"},{"issue":"12","key":"14145_CR4","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","volume":"28","author":"N Ahmadi","year":"2021","unstructured":"Ahmadi N, Kostadinov D, Sakata S, et al. Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons. Ann Surg Oncol. 2021;28(12):7809\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"14145_CR5","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1245\/s10434-021-11233-1","volume":"29","author":"F Lopez-Ramirez","year":"2022","unstructured":"Lopez-Ramirez F, Gushchin V, Sittig M, et al. Iterative cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous adenocarcinoma of the appendix. Ann Surg Oncol. 2022;29(6):3390\u2013401.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"14145_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","volume":"41","author":"AC Lord","year":"2015","unstructured":"Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol. 2015;41(3):396\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"14145_CR7","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1245\/s10434-019-07374-z","volume":"26","author":"C Munoz-Zuluaga","year":"2019","unstructured":"Munoz-Zuluaga C, King MC, Sardi A, et al. Selection and characteristics of patients with peritoneal dissemination from appendiceal cancer with exceptional\/poor survival after CRS\/HIPEC. Ann Surg Oncol. 2019;26(7):2268\u201375.","journal-title":"Ann Surg Oncol"},{"key":"14145_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","volume":"27","author":"Chicago Consensus Working Group","year":"2020","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol. 2020;27:1753\u201360. https:\/\/doi.org\/10.1245\/s10434-020-08316-w.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"14145_CR9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1245\/s10434-019-07218-w","volume":"26","author":"HA Choudry","year":"2019","unstructured":"Choudry HA, Bednar F, Shuai Y, et al. Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases. Ann Surg Oncol. 2019;26(5):1445\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"14145_CR10","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1245\/s10434-022-11894-6","volume":"29","author":"E Baron","year":"2022","unstructured":"Baron E, Sardi A, King MC, et al. Systemic chemotherapy for high-grade mucinous appendiceal cancer with peritoneal spread after unsuccessful CRS\/HIPEC. Ann Surg Oncol. 2022;29(11):6581\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"14145_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jso.26371","volume":"123","author":"A Nikiforchin","year":"2021","unstructured":"Nikiforchin A, Gushchin V, King MC, et al. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 2021;123(4):1030\u201344.","journal-title":"J Surg Oncol"},{"issue":"6","key":"14145_CR12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","volume":"71","author":"NJ Carr","year":"2017","unstructured":"Carr NJ, Bibeau F, Bradley RF, et al. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology. 2017;71(6):847\u201358.","journal-title":"Histopathology"},{"issue":"1","key":"14145_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1245\/s10434-019-07678-0","volume":"27","author":"D Solomon","year":"2020","unstructured":"Solomon D, Bekhor E, Leigh N, et al. Surveillance of Low-grade appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: are 5 years enough? A multisite experience. Ann Surg Oncol. 2020;27(1):147\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"14145_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215(3):412\u20137.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"14145_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69\u201376.","journal-title":"Lancet Oncol"},{"key":"14145_CR16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB. AJCC cancer staging manual. New York: Springer; 2017."},{"issue":"7","key":"14145_CR17","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1245\/s10434-019-08117-w","volume":"27","author":"E Baron","year":"2020","unstructured":"Baron E, Milovanov V, Gushchin V, Sittig M, Neiroda C, Sardi A. Predicting aborted hyperthermic intraperitoneal chemotherapy (AHIPEC) with preoperative tumor and inflammatory markers in potentially resectable appendiceal cancer patients with peritoneal carcinomatosis. Ann Surg Oncol. 2020;27(7):2548\u201356.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14145_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol. 2016;40(1):14\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"14145_CR19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: An analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61(3):347\u201354.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"14145_CR20","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T","volume":"77","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77(12):2622\u20139.","journal-title":"Cancer"},{"issue":"2","key":"14145_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"2","key":"14145_CR22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1245\/s10434-021-10669-9","volume":"29","author":"A Nikiforchin","year":"2022","unstructured":"Nikiforchin A, Gushchin V, Sittig M, et al. Outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy with and without diaphragmatic resection in patients with peritoneal metastases. Ann Surg Oncol. 2022;29(2)873\u201382.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"14145_CR23","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1245\/s10434-022-12862-w","volume":"30","author":"A Nikiforchin","year":"2023","unstructured":"Nikiforchin A, Sardi A, King MC, et al. Safety of nephrectomy performed during CRS\/HIPEC: a propensity score-matched study. Ann Surg Oncol. 2023;30(4):2520\u20138. https:\/\/doi.org\/10.1245\/s10434-022-12862-w.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"14145_CR24","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1245\/s10434-021-10298-2","volume":"28","author":"A Nikiforchin","year":"2021","unstructured":"Nikiforchin A, Gushchin V, King MC, Baron E, Lopez-Ramirez F, Sardi A. Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for patients with intrapleural dissemination of peritoneal surface malignancies. Ann Surg Oncol. 2021;28(13):9126\u201335.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"14145_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bjs5.97","volume":"3","author":"F Mercier","year":"2019","unstructured":"Mercier F, Dagbert F, Pocard M, et al. Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open. 2019;3(2):195\u2013202.","journal-title":"BJS Open"},{"issue":"2","key":"14145_CR26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-018-6860-4","volume":"26","author":"Y Feferman","year":"2019","unstructured":"Feferman Y, Solomon D, Bhagwandin S, et al. Sites of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis from colorectal and appendiceal adenocarcinoma: a tertiary center experience. Ann Surg Oncol. 2019;26(2):482\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14145_CR27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-019-07932-5","volume":"27","author":"K Zambrano-Vera","year":"2020","unstructured":"Zambrano-Vera K, Sardi A, Munoz-Zuluaga C, et al. Outcomes in peritoneal carcinomatosis from appendiceal goblet cell carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). Ann Surg Oncol. 2020;27(1):179\u201387.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"14145_CR28","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clcc.2020.01.002","volume":"19","author":"NR Sluiter","year":"2020","unstructured":"Sluiter NR, van der Bilt JD, Croll DMR, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) versus surgery without HIPEC for goblet-cell carcinoids and mixed adenoneuroendocrine carcinomas: propensity score-matched analysis of centers in the Netherlands and Belgium. Clin Colorectal Cancer. 2020;19(3):e87-99.","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"14145_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1245\/s10434-017-6272-x","volume":"25","author":"AH Madsen","year":"2018","unstructured":"Madsen AH, Ladekarl M, Villadsen GE, et al. Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: a prospective cohort study. Ann Surg Oncol. 2018;25(2):422\u201330.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"14145_CR30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","volume":"23","author":"CH Lieu","year":"2012","unstructured":"Lieu CH, Lambert LA, Wolff RA, et al. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol. 2012;23(3):652\u20138.","journal-title":"Ann Oncol"},{"issue":"1","key":"14145_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","volume":"24","author":"NC Levinsky","year":"2020","unstructured":"Levinsky NC, Morris MC, Wima K, et al. Should we be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC collaborative. J Gastrointest Surg. 2020;24(1):155\u201364.","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"14145_CR32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","volume":"109","author":"AU Blackham","year":"2014","unstructured":"Blackham AU, Swett K, Eng C, et al. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109(7):740\u20135.","journal-title":"J Surg Oncol"},{"issue":"5","key":"14145_CR33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejso.2015.01.005","volume":"41","author":"V Milovanov","year":"2015","unstructured":"Milovanov V, Sardi A, Ledakis P, et al. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). Eur J Surg Oncol. 2015;41(5):707\u201312.","journal-title":"Eur J Surg Oncol"},{"key":"14145_CR34","first-page":"163284","volume":"2012","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH. Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival. Gastroenterol Res Pract. 2012;2012:163284.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"14145_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejso.2022.08.022","volume":"49","author":"E Baron","year":"2023","unstructured":"Baron E, Sardi A, King MC, et al. Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2023;49(1):179\u201387. https:\/\/doi.org\/10.1016\/j.ejso.2022.08.022.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"14145_CR36","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/cam4.3009","volume":"9","author":"BC Kolla","year":"2020","unstructured":"Kolla BC, Petersen A, Chengappa M, et al. Impact of adjuvant chemotherapy on outcomes in appendiceal cancer. Cancer Med. 2020;9(10):3400\u20136.","journal-title":"Cancer Med"},{"key":"14145_CR37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jss.2022.10.085","volume":"284","author":"DN Hanna","year":"2023","unstructured":"Hanna DN, Macfie R, Ghani MO, et al. Association of systemic chemotherapy approaches with outcomes in appendiceal peritoneal metastases. J Surg Res. 2023;284:94\u2013100.","journal-title":"J Surg Res"},{"issue":"2","key":"14145_CR38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","volume":"26","author":"C Munoz-Zuluaga","year":"2019","unstructured":"Munoz-Zuluaga C, Sardi A, King MC, et al. Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(2):473\u201381.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14145_CR39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Zaidi MY, Lee RM, et al. Optimal surveillance frequency after CRS\/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol. 2020;27(1):134\u201346.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14145_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh I, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):11\u201335.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"14145_CR41","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1245\/s10434-018-6488-4","volume":"25","author":"HA Choudry","year":"2018","unstructured":"Choudry HA, Pai RK. Management of mucinous appendiceal tumors. Ann Surg Oncol. 2018;25(8):2135\u201344.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"14145_CR42","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1245\/s10434-020-08535-1","volume":"27","author":"A Nikiforchin","year":"2020","unstructured":"Nikiforchin A, King MC, Baron E, et al. Impact of mucin cellularity and distribution on survival in newly diagnosed patients with low-grade appendiceal mucinous neoplasm treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27(13):4908\u201317.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"14145_CR43","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","volume":"94","author":"ME McCusker","year":"2002","unstructured":"McCusker ME, Cot\u00e9 TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973\u20131998. Cancer. 2002;94(12):3307\u201312.","journal-title":"Cancer"},{"issue":"13","key":"14145_CR44","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1245\/s10434-020-08844-5","volume":"27","author":"CA Munoz-Zuluaga","year":"2020","unstructured":"Munoz-Zuluaga CA, King MC, Diaz-Sarmiento VS, et al. Defining \u201ccomplete cytoreduction\u201d after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) for the histopathologic spectrum of appendiceal carcinomatosis. Ann Surg Oncol. 2020;27(13):5026\u201336.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"14145_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dld.2021.10.005","volume":"54","author":"JB Delhorme","year":"2022","unstructured":"Delhorme JB, Villeneuve L, Bouch\u00e9 O, et al. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis. 2022;54(1):30\u20139.","journal-title":"Dig Liver Dis"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14145-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:14:51Z","timestamp":1696878891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14145-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["14145"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14145-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}